| 產(chǎn)品編號(hào) | Ys-1119R |
| 英文名稱 | PAF |
| 中文名稱 | 血小板活化因子抗體 |
| 別 名 | platelet-activating factor; 1-Hexadecyl-2-acetyl-sn-glycero-3-phosphocholine; 1-O-Palmityl-2-acetyl-sn-glycero-3-phosphocholine monohydrate; 2-Acetyl-1-hexadecyl-sn-glycero-3-phosphocholine; 3-sn-Phosphatidylcholine; 1-hexadecyl-2-acetyl, PAF(C16. |
| 產(chǎn)品類型 | 小分子抗體 |
| 研究領(lǐng)域 | 藥物及化合物 |
| 抗體來源 | Rabbit |
| 克隆類型 | Polyclonal |
| 交叉反應(yīng) | Rat, |
| 產(chǎn)品應(yīng)用 | ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蠟切片需做抗原修復(fù)） not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 理論分子量 | 0.524kDa |
| 性 狀 | Liquid |
| 濃 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated PAF |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 緩 沖 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| 保存條件 | Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| PubMed | PubMed |
| 產(chǎn)品介紹 | Platelet-activating factor, a compound that reduces inflammation by increasing permeability of blood vessels and contracting various involuntary muscles such as those in airways. It is a phospholipid with a wide range of proinflammatory actions, is immediately degraded and inactivated in vivo by PAF acetylhydrolase. SWISS: N/A CAS: 74389-68-7 血小板活化因子（platelet-activating factor，PAF）是一種內(nèi)源性具有生物活性的磷脂。由中性粒細(xì)胞、血小板、肥大細(xì)胞、內(nèi)皮細(xì)胞和巨噬細(xì)胞產(chǎn)生。除早期發(fā)現(xiàn)它有強(qiáng)烈引起血小板聚集和脫顆粒作用外，近年來的研究發(fā)現(xiàn)它還具有廣泛的生物活性，作為一種獨(dú)特的細(xì)胞因子參與體內(nèi)多種生理、病理過程，包括激活中性粒細(xì)胞，使其聚集、趨化、釋放氧自由基和白三烯，抑制T細(xì)胞增殖，刺激B細(xì)胞合成IgG和IgE，抑制心肌收縮力，增加血管通透性，引起體循環(huán)血壓下降和肺動(dòng)脈高壓等。由于它具有廣泛的高強(qiáng)度的生物活性，故PAF被認(rèn)為是與過敏反應(yīng)有關(guān)的關(guān)鍵性介質(zhì)之一。 |
| 產(chǎn)品圖片 | |
我要詢價(jià)
*聯(lián)系方式：
(可以是QQ、MSN、電子郵箱、電話等，您的聯(lián)系方式不會(huì)被公開)
*內(nèi)容：
